Nobel Biocare today announced that Dirk Kirsten, CFO of Nobel Biocare, has decided to resign from his position as Chief Financial Officer by 31 January 2013 to pursue other opportunities outside of Nobel Biocare. Nobel Biocare will inform on his successor in due course.
Nobel Biocare would like to thank Dirk Kirsten for his effort and commitment to the company and wishes him all the best for the future.
Nobel Biocare is a world leader in the field of innovative implant-based dental restorations. The company’s portfolio offers solutions from single tooth to fully edentulous indications with dental implant systems (including key brands NobelActive®, Brånemark System® and NobelReplace®), a comprehensive range of high-precision individualized prosthetics and CAD/CAM systems (NobelProcera®), diagnostics, treatment planning and guided surgery solutions (NobelClinician® and DTX Studio™) and biomaterials (creos™). Nobel Biocare supports its customers through all phases of professional development, offering world-class training and education along with practice support and patient information materials. The company is headquartered in Zurich, Switzerland. Production takes place at six sites located in the United States, Sweden, Japan and Israel. Products and services are available in over 80 countries through subsidiaries and distributors.